ACCC announces six winners of 2015 Innovator Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE ASSOCIATION OF COMMUNITY CANCER CENTERS announced the six winners of its 2015 Innovator Awards.

This year’s winners are:

  • Eastern Maine Medical Center Cancer Program, for improving efficiency, safety and the patient experience with location technology.
  • Lancaster General Hospital and the Ann B. Barshinger Cancer Institute, for creating a Cancer Patient Support Fund for patients experiencing financial distress.
  • Mary Washington Healthcare Regional Cancer Center, for the center’s focused “prehabilitation” program that couples physical therapy with holistic care that includes nutritional support, stress reduction strategies and nurse navigator intervention, which decreased hospital length of stay for thoracic oncology patients by 40 percent.
  • PIH Health Comprehensive Community Cancer Program, for its nurse practitioner-run Lung Cancer Screening Program that utilizes an enrollment method that allows primary care practitioners to refer patients or for the patient to self-refer.
  • Providence Cancer Center, which offers a supportive group model to deliver early and ongoing intervention and support throughout cancer care and creating a framework to talk about the impact of cancer on the family.
  • The Seton Cancer Program of the Seton Family of Hospitals, for developing a standardized, integrated database of clinical and business metrics to measure, analyze and improve patient care and operational efficiency.

More details about each program are available on the ACCC website.

YOU MAY BE INTERESTED IN

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login